Acumen Pharmaceuticals
ABOS
ABOS
80 hedge funds and large institutions have $176M invested in Acumen Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
63% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $4.13M
Holders
80
Holding in Top 10
1
Calls
$1.54M
Puts
$4.13M
Top Buyers
| 1 | +$8.46M | |
| 2 | +$4.59M | |
| 3 | +$4.45M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$836K |
| 5 |
Goldman Sachs
New York
|
+$823K |
Top Sellers
| 1 | -$948K | |
| 2 | -$707K | |
| 3 | -$530K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$436K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$417K |